By analyzing blood samples of CLL and DLBCL patients, we observed a higher proportion of PD-1-expressing CD4+ T cells in both patient groups compared to HC thus confirming published data [6–10]. This evidence concerns the gene CD4 and diffuse large B-cell lymphoma.